ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 104 filers reported holding ARATANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -60.0% | 710 | -55.6% | 0.00% | – |
| Q4 2018 | $10,000 | -28.6% | 1,600 | -33.1% | 0.00% | – |
| Q3 2018 | $14,000 | +100.0% | 2,391 | +40.6% | 0.00% | – |
| Q2 2018 | $7,000 | +133.3% | 1,700 | +176.4% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 615 | -24.0% | 0.00% | – |
| Q4 2017 | $4,000 | -84.0% | 809 | -80.4% | 0.00% | – |
| Q3 2017 | $25,000 | +400.0% | 4,125 | +484.3% | 0.00% | – |
| Q2 2017 | $5,000 | -54.5% | 706 | -67.3% | 0.00% | – |
| Q1 2017 | $11,000 | +120.0% | 2,159 | +189.4% | 0.00% | – |
| Q4 2016 | $5,000 | – | 746 | +3008.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 24 | -99.4% | 0.00% | – |
| Q1 2016 | $22,000 | +100.0% | 4,000 | +97.7% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 2,023 | +81.1% | 0.00% | – |
| Q3 2015 | $9,000 | -50.0% | 1,117 | -7.9% | 0.00% | – |
| Q2 2015 | $18,000 | +260.0% | 1,213 | +304.3% | 0.00% | – |
| Q3 2013 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $1,219,000 | 11.21% |
| Broadfin Capital, LLC | 3,428,865 | $19,133,000 | 1.18% |
| MPM ASSET MANAGEMENT LLC | 1,117,875 | $6,238,000 | 1.11% |
| AlpInvest Partners B.V. | 100,001 | $558,000 | 0.93% |
| First Light Asset Management, LLC | 395,043 | $2,204,000 | 0.92% |
| Westend Capital Management, LLC | 89,780 | $501,000 | 0.69% |
| Grandeur Peak Global Advisors, LLC | 460,675 | $2,571,000 | 0.53% |
| AWM Investment Company, Inc. | 467,507 | $2,609,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 111,705 | $623,000 | 0.27% |
| Sio Capital Management, LLC | 97,376 | $543,000 | 0.24% |